Orthofix Medical (OFIX) gains 27% in a month as investors react to favorable CMS policy change and broader small-cap rotation.
Orthofix Medical Inc. (NASDAQ:OFIX) climbed to $11.02 per share on July 22, 2026, marking a 27.03% one-month return. The rally follows the Centers for Medicare & Medicaid Services (CMS) reversing a planned reimbursement cut, easing investor concerns over revenue stability.
The company’s 52-week trading range spans $8.85 to $16.99, with a market capitalization of $441.80 million. Year-to-date, OFIX shares have risen 4.14%, outperforming broader benchmarks amid a shift toward undervalued small and mid-cap stocks.
Rewey Asset Management’s Q2 2026 investor letter highlighted OFIX as a top performer, citing the CMS decision and strong capital markets, where IPOs raised $104 billion in 48 deals.